{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:24:43Z","timestamp":1784615083396,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"NIDDK\/NIH","award":["U01DK065211 (Indiana University)"],"award-info":[{"award-number":["U01DK065211 (Indiana University)"]}]},{"name":"NIDDK\/NIH","award":["U01DK065184 (University of Michigan)"],"award-info":[{"award-number":["U01DK065184 (University of Michigan)"]}]},{"name":"NIDDK\/NIH","award":["U01DK065201 (University of North Carolina-Chapel Hill)"],"award-info":[{"award-number":["U01DK065201 (University of North Carolina-Chapel Hill)"]}]},{"name":"NIDDK\/NIH","award":["U01DK083020 (University of Southern California)"],"award-info":[{"award-number":["U01DK083020 (University of Southern California)"]}]},{"name":"NIDDK\/NIH","award":["U01DK083027 (Thomas Jefferson University\/Albert Einstein Medical Center)"],"award-info":[{"award-number":["U01DK083027 (Thomas Jefferson University\/Albert Einstein Medical Center)"]}]},{"name":"NIDDK\/NIH","award":["U01DK100928 (Icahn School of Medicine at Mount Sinai)"],"award-info":[{"award-number":["U01DK100928 (Icahn School of Medicine at Mount Sinai)"]}]},{"name":"NIDDK\/NIH","award":["U24DK065176 (Duke University)."],"award-info":[{"award-number":["U24DK065176 (Duke University)."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s40264-024-01484-8","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T19:02:02Z","timestamp":1727809322000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8298-5381","authenticated-orcid":false,"given":"Dina","family":"Halegoua-DeMarzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi","family":"Avula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiman","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"A. Sidney","family":"Barritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan S.","family":"Ghabril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlas","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Odin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoss","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averell H.","family":"Sherker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans L.","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Drug-Induced Liver Injury Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"1484_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.21037\/tgh.2017.11.16","volume":"2","author":"ES Bj\u00f6rnsson","year":"2017","unstructured":"Bj\u00f6rnsson ES, Bj\u00f6rnsson HK. Mortality associated with drug-induced liver injury (DILI). Transl Gastroenterol Hepatol. 2017;2:114.","journal-title":"Transl Gastroenterol Hepatol."},{"issue":"6","key":"1484_CR2","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","volume":"135","author":"N Chalasani","year":"2008","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, Drug Induced Liver Injury Network (DILIN), et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135(6):1924\u201334 (1934.e1-4).","journal-title":"Gastroenterology"},{"key":"1484_CR3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/livers3040041","volume":"3","author":"JK-S Lin","year":"2023","unstructured":"Lin JK-S, Tujios SR. Hidden dangers: herbal and dietary supplement induced hepatotoxicity. Livers. 2023;3:618\u201336.","journal-title":"Livers"},{"issue":"7","key":"1484_CR4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, United States Drug Induced Liver Injury Network, et al. Features and outcomes of 889 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340\u201352.","journal-title":"Gastroenterology"},{"issue":"1","key":"1484_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","volume":"32","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-induced liver injury network (DILIN) prospective study: rationale, design and con- duct. Drug Saf. 2009;32(1):55\u201368.","journal-title":"Drug Saf"},{"issue":"4","key":"1484_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/hep.27317","volume":"60","author":"VJ Navarro","year":"2014","unstructured":"Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. drug-induced liver injury network. Hepatology. 2014;60(4):1399\u2013408.","journal-title":"Hepatology"},{"issue":"1","key":"1484_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363\u201373.","journal-title":"Hepatology"},{"issue":"46","key":"1484_CR8","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.3748\/wjg.v25.i46.6704","volume":"25","author":"P Grewal","year":"2019","unstructured":"Grewal P, Ahmad J. Severe liver injury due to herbal and dietary supplements and the role of liver transplantation. World J Gastroenterol. 2019;25(46):6704\u201312.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1484_CR9","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/hep.23577","volume":"51","author":"DC Rockey","year":"2010","unstructured":"Rockey DC, Seeff LB, Rochon J, US Drug-Induced Liver Injury Network, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51(6):2117\u201326.","journal-title":"Hepatology"},{"key":"1484_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","volume":"11","author":"C Benichou","year":"1990","unstructured":"Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11:272\u20136.","journal-title":"J Hepatol"},{"key":"1484_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","volume":"46","author":"C Benichou","year":"1993","unstructured":"Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs\u2014II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993;46:1331\u20136.","journal-title":"J Clin Epidemiol"},{"key":"1484_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hep.510260319","volume":"26","author":"VA Maria","year":"1997","unstructured":"Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26:664\u20139.","journal-title":"Hepatology"},{"key":"1484_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1484_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1365-2036.2008.03655.x","volume":"27","author":"M Garcia-Cortes","year":"2008","unstructured":"Garcia-Cortes M, Lucena MI, Pachkoria K, et al. Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 2008;27:780\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1484_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3389\/fphar.2019.00853","volume":"10","author":"G Danan","year":"2019","unstructured":"Danan G, Teschke R. Roussel Uclaf causality assessment method for drug-induced liver injury: present and future. Front Pharmacol. 2019;10:853.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1484_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hep.32327","volume":"76","author":"PH Hayashi","year":"2022","unstructured":"Hayashi PH, Lucena MI, Fontana RJ, et al. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology. 2022;76(1):18\u201331.","journal-title":"Hepatology"},{"key":"1484_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cld.2019.09.009","volume":"24","author":"E Zheng","year":"2020","unstructured":"Zheng E, Sandhu N, Navarro V. Drug-induced liver injury secondary to herbal and dietary supplements. Clin Liver Dis. 2020;24:141\u201355.","journal-title":"Clin Liver Dis"},{"issue":"6","key":"1484_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep4.1346","volume":"3","author":"V Navarro","year":"2019","unstructured":"Navarro V, Avula B, Khan I, et al. The contents of herbal and dietary supplements implicated in liver injury in the united states are frequently mislabeled. Hepatol Commun. 2019;3(6):792\u20134.","journal-title":"Hepatol Commun"},{"issue":"4","key":"1484_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00042752-200110000-00008","volume":"11","author":"GA Green","year":"2001","unstructured":"Green GA, Catlin DH, Starcevic B. Analysis of over-the-counter dietary supplements. Clin J Sport Med. 2001;11(4):254\u20139.","journal-title":"Clin J Sport Med"},{"issue":"6","key":"1484_CR20","doi-asserted-by":"publisher","first-page":"e183337","DOI":"10.1001\/jamanetworkopen.2018.3337","volume":"1","author":"J Tucker","year":"2018","unstructured":"Tucker J, Fischer T, Upjohn L, et al. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Netw Open. 2018;1(6):e183337.","journal-title":"JAMA Netw Open"},{"key":"1484_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/tgh-20-149","volume":"6","author":"R Teschke","year":"2021","unstructured":"Teschke R, Eickhoff A, Schulze J, et al. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf causality assessment method (RUCAM): an overview. Transl Gastroenterol Hepatol. 2021;6:51.","journal-title":"Transl Gastroenterol Hepatol."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-024-01484-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T14:05:18Z","timestamp":1738332318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-024-01484-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1007\/s40264-024-01484-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"1 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health under award nos. U01DK065211 (Indiana University), U01DK065184 (University of Michigan), U01DK065201 (University of North Carolina-Chapel Hill), U01DK083020 (University of Southern California), U01DK083027 (Thomas Jefferson University\/Albert Einstein Medical Center), U01DK100928 (Icahn School of Medicine at Mount Sinai), and U24DK065176 (Duke University). Additional support is provided by the intramural programs of the NIDDK and the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors have no disclosures related to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Advarra Institutional Review Board. Protocol title: A Multi-Center Study of Drug-and HDS-Induced Liver Injury (DILIN). Protocol approval #: Pro00072297. Approval date: 5 January 2024. All procedures performed in the study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients who participated in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Available upon reasonable request, following applicable regulations, by contacting the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material data"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors read and approved the final version. D.H.D. was responsible for analysis and interpretation of data, drafting of the manuscript, and critical revision of the manuscript for important intellectual content and statistical analysis; V.N. for study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, statistical analysis, obtaining funding, and study supervision; A.D. for study concept and design, acquisition of data, and analysis and interpretation of data; B.A. for analysis and interpretation of data, acquisition of data, and critical revision of the manuscript for important intellectual content; H.B. for study concept and design, acquisition of data, analysis and interpretation of data critical revision of the manuscript for important intellectual content, and statistical analysis; A.S.B. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; J.A. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; H.L.B. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; V.L.C. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; G.C. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; R.J.F. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; M.S.G. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; I.A.K. for analysis and interpretation of data and critical revision of the manuscript for important intellectual content; C.K. for analysis and interpretation of data and critical revision of the manuscript for important intellectual content; J.O. for analysis and interpretation of data and critical revision of the manuscript for important intellectual content; H.R. for acquisition of data; J.S. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; A.H.S. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; A.S. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; H.L.D. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content; and R.V. for study concept and design, acquisition of data, and analysis and interpretation of data critical revision of the manuscript for important intellectual content.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}